HAL will be down for maintenance from Friday, June 10 at 4pm through Monday, June 13 at 9am. More information
Skip to Main content Skip to Navigation
Journal articles

Methadone in primary care in France: Using evidence for action against hepatitis C

P. Roux 1 A. Morel 2 D. Wolfe 3 Patrizia Carrieri 1
1 SESSTIM - U1252 INSERM - Aix Marseille Univ - UMR 259 IRD - Sciences Economiques et Sociales de la Santé & Traitement de l'Information Médicale
2 Association de prévention et de soin en addictologie - Oppelia [Paris]
3 OSI - Open Society Foundations
Abstract : In France, two opioid substitution treatments have been available since the mid-1990s: buprenorphine through primary care and specialized clinics, and methadone only through specialized clinics.
Keywords : Scientific evidence Advocacy Primary care Hepatitis C Methadone
Document type :
Journal articles
Complete list of metadata
https://hal-amu.archives-ouvertes.fr/hal-02613452
Contributor : Accord Elsevier Ccsd Connect in order to contact the contributor
Submitted on : Monday, October 25, 2021 - 12:56:20 PM
Last modification on : Wednesday, November 3, 2021 - 5:22:14 AM
Long-term archiving on: : Wednesday, January 26, 2022 - 7:56:19 PM

File

Vignette du document
S0955395919301689.pdf
Files produced by the author(s)

Licence

Distributed under a Creative Commons Attribution - NonCommercial 4.0 International License
Elsevier-hosted Accepted Manuscript

Identifiers

Collections

UNIV-AMU | INSERM | U1252 | IRD

Citation

P. Roux, A. Morel, D. Wolfe, Patrizia Carrieri. Methadone in primary care in France: Using evidence for action against hepatitis C. International Journal of Drug Policy, Elsevier, 2019, 71, pp.91-92. ⟨10.1016/j.drugpo.2019.06.013⟩. ⟨hal-02613452⟩

Export

BibTeX TEI DC DCterms EndNote Datacite

Share

Metrics

Record views

33

Files downloads

20